NCT03297515View on ClinicalTrials.gov

Therapeutic Potential of Omega-3 Fatty Acids Supplementation in Dry Macular Degeneration and Stargardt Disease

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 15, 2019

Primary Completion Date

September 22, 2020

Study Completion Date

September 22, 2020

Conditions

Dry AMDStargardt Disease 1

Interventions

DIETARY_SUPPLEMENT

Madeos

Arm 1: Omega 3

DIETARY_SUPPLEMENT

Placebo

Arm 2 : Placebo

Trial Locations (5)

Unknown

Centre National d'Ophtalmologie des Quinze-Vingts, Paris

Department of Ophthalmology, Justus-Liebig-University-Giessen, Giessen

Università degli Studi G. d'Annunzio Chieti-Pescara, Chieti

ASST Santi Paolo e Carlo, Milan

Department of Ophthalmology, University Vita Salute, Milan

All Listed Sponsors

lead

Ophthalmos Research and Education Institute

OTHER

NCT03297515 - Therapeutic Potential of Omega-3 Fatty Acids Supplementation in Dry Macular Degeneration and Stargardt Disease | Biotech Hunter | Biotech Hunter